Revance Therapeutics, Inc. | ||||
NGM : RVNC || Location: United States | ||||
$4.92-0.02 (-0.4%) |
1.25 M | 4.86 - 5.03 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 15, 2024 | 10.866 M |
Feb. 29, 2024 | 11.879 M |
Feb. 15, 2024 | 12.340 M |
Jan. 31, 2024 | 12.648 M |
Jan. 12, 2024 | 14.805 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.74 | -0.62 | 16.06% |
09/30/2023 | -0.87 | -1.63 | -87.33% |
06/30/2023 | -0.79 | -0.80 | -0.84% |
03/31/2023 | -0.71 | -0.74 | -3.83% |
12/31/2022 | -0.97 | -0.95 | 1.86% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 104.216M | Shares Float | 70.798M |
Short Float | 10.866M | Market Cap | 514.83M |
Institution ownership | 76.00% | Insider ownership | 8.475% |
Earnings Date | 05/06/2024 AMC | Cash Per Share | ? |
Trailing EPS | -3.83 | Forward EPS | -1.06 |